Roswell Biotechnologies

Roswell Biotechnologies is a San Diego-based molecular electronics company pioneering a fundamentally new approach to DNA sequencing by digitizing biology at the molecular level. The company has developed the world's first molecular electronics chip, which uses single-molecule protein bridges to enable ultra-fast, low-cost DNA sequencing at unprecedented scale. Roswell's platform leverages molecular electronics — where individual molecules serve as circuit components — to predict, prevent, and cure disease by elucidating biological information with far greater precision than existing sequencing technologies. The company raised a $32 million Series A financing round in 2019 and has continued advancing its microchip-based molecular electronics platform in collaboration with leading research institutions.